Source: http://isomerdesign.com/Cdsa/scheduleUS.php?schedule=3&section=ALL
Timestamp: 2018-09-20 08:56:04
Document Index: 727211886

Matched Legal Cases: ['§308', 'art 1', 'art 1', 'art 2', 'art 1', 'art 2', 'art 1', 'art 1', 'art 2', 'art 1', 'art 2', 'art 1', 'art 2', '§1300']

Controlled Substances Act : Legislative history · Schedule III · All sections
Section (a) to (b): Prologue to Opiates
Section (c): Opium derivatives
Section (d): Hallucinogenic substances
Section (e) to (f): Depressants to Stimulants
Section (g): Cannabimimetic agents
Section (h): Temporary/emergency scheduling
Section (a) to (b): Prologue to Substances, vegetable, chemical
Section (c): Opiates
Section (d) to (e): Stimulants to Depressants
Section (f) to (g): Hallucinogenic substances to Immediate precursors
Section (a) to (b): Prologue to Stimulants
Section (c): Depressants
Section (d) to (e): Nalorphine to Narcotic drugs
Section (f): Anabolic steroids
Section (g): Hallucinogenic substances
Section (a) to (b): Prologue to Narcotic drugs
Section (d) to (f): Fenfluramine to Stimulants
Section (g): Other substances
Section (a) to (c): Prologue to Narcotic drugs etc.
Section (a): List I chemicals
Section (b): List II chemicals
Schedule III [21 CFR 1308.13]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous sxstem[sic], including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Effective 7 Jul 1971, 36 FR 12734 revoked (and renumbered subsequent entries):
On 26 May 1971, 36 FR 9563 proposed to revoke (and to renumber subsequent entries:)
Amphetamine, its salts, optical isomers, and salts of its optical isomers.
US: Currently at CSA Schedule II Section d Subsection 1 Amphetamine
Effective 28 Oct 1971, 36 FR 20686 revoked (and renumbered subsequent entries):
Phenmetrazine and its salts.
US: Currently at CSA Schedule II Section d Subsection 3 Phenmetrazine
Any substance (except an injectable liquid) which contains any quantity of Methamphetamine, including its salts, isomers, and salts of isomers.
US: Currently at CSA Schedule II Section d Subsection 2 Methamphetamine
US: Currently at CSA Schedule II Section d Subsection 4 Methylphenidate
Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Sec. 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances
Effective 31 Dec 1969, replacement for:
Effective 15 Jun 1973, 38 FR 15719 replacement for:
Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under §308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.
On 26 May 1971, 36 FR 9563 proposed to add:
Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances which are currently listed as exected compounds under 21 CFR 308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.
Effective 7 Jul 1971, 36 FR 12734 added:
Effective 15 Jun 1973, 38 FR 15719 added:
On 9 May 1973, 38 FR 12119 proposed to add:
CA: CDSA Schedule I Section 19 Subsection 17 Benzphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 18 Benzphetamine
UK: MDA Part III Class C Section 1(a) Benzphetamine
UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
PubChem: 2341; ChemSpider: 2251; Wikipedia: Benzphetamine
On 9 May 1973, 38 FR 12120 proposed to add:
CA: CDSA Schedule IV Section 3 Chlorphentermine
UK: MDA Part III Class C Section 1(a) Chlorphentermine
PubChem: 10007; ChemSpider: 9613; Wikipedia: Chlorphentermine
On 9 May 1973, 38 FR 12121 proposed to add:
PubChem: 25223; ChemSpider: 23558; Wikipedia: Clortermine
On 9 May 1973, 38 FR 12230 proposed to add:
US: Currently at CSA Schedule IV Section f Subsection 2 Diethylpropion
Effective 27 Nov 1981, 46 FR 52333 revoked (and renumbered subsequent entries):
On 9 May 1973, 38 FR 12124 proposed to add:
US: Currently at CSA Schedule IV Section f Subsection 5 Mazindol
On 9 May 1973, 38 FR 12126 proposed to add:
CA: CDSA Schedule IV Section 5 Phendimetrazine
UK: MDA Part III Class C Section 1(a) Phendimetrazine
UN: Psychotropics Schedule IV Phendimetrazine
PubChem: 12460; ChemSpider: 11950; Drugs Forum: Phendimetrazine; Wikipedia: Phendimetrazine
On 9 May 1973, 38 FR 12127 proposed to add:
US: Currently at CSA Schedule IV Section f Subsection 9 Phentermine
Effective 13 Nov 1973, 38 FR 31310 renumbered:
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
Effective 13 Nov 1973, 38 FR 31310 added (and renumbered subsequent entries):
Any compound, mixture or preparation containing Amobarbital, Secobarbital, Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CA: CDSA Schedule IV Section 1 Subsection 3 Amobarbital
UN: Psychotropics Schedule III Amobarbital
See also CSA Schedule II Section e Subsection 1 Amobarbital and Schedule III Section c Subsection 2 Item i Amobarbital
PubChem: 2164; ChemSpider: 2079; Erowid: Barbiturates; Wikipedia: Amobarbital
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
UN: Psychotropics Schedule II Secobarbital
See also CSA Schedule II Section e Subsection 5 Secobarbital and Schedule III Section c Subsection 2 Item ii Secobarbital
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
UN: Psychotropics Schedule III Pentobarbital
See also CSA Schedule II Section e Subsection 3 Pentobarbital and Schedule III Section c Subsection 2 Item iii Pentobarbital
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital
Any suppository dosage form containing containing Amobarbital, Secobarbital, Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
See also CSA Schedule II Section e Subsection 1 Amobarbital and Schedule III Section c Subsection 1 Item i Amobarbital
See also CSA Schedule II Section e Subsection 5 Secobarbital and Schedule III Section c Subsection 1 Item ii Secobarbital
Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
See also CSA Schedule II Section e Subsection 3 Pentobarbital and Schedule III Section c Subsection 1 Item iii Pentobarbital
Any substance which contains any quantity of a derivative of Barbituric acid or any salt thereof
Effective 13 Nov 1973, 38 FR 31310 replacement for:
Any substance which contains any quantity of a derivative of Barbituric acid, or any salt of a derivative of Barbituric acid.
CA: CDSA Schedule IV Section 1 Subsection 6 Barbituric acid
PubChem: 6211; ChemSpider: 5976; Erowid: Barbiturates; Wikipedia: Barbituric acid
PubChem: 19094; ChemSpider: 18027; Wikipedia: Chloralodol
Effective 28 Sep 2006, 71 FR 51115 added (and renumbered subsequent entries):
On 29 Aug 2005, 70 FR 50996 extended the comment period of the earlier proposal to 28 Sept 2005 from 29 Aug 2005
On 29 Jul 2005, 70 FR 43809 proposed to add (and to renumber subsequent entries):
PubChem: 27453; ChemSpider: 25547; Wikipedia: Embutramide
Effective 21 Mar 1991, 56 FR 11930 revoked (and renumbered subsequent entries):
US: Currently at CSA Schedule II Section e Subsection 2 Glutethimide
Effective 3 Apr 2000, 65 FR 17440 corrected an error in amendatory instruction 3 of 68 FR 13235
Effective 13 Mar 2000, 65 FR 13235 added (and renumbered subsequent entries):
Any drug product containing Gamma-hydroxybutyric acid (GHB; Gamma-hydroxybutyrate; 4-Hydroxybutyrate; 4-Hydroxybutanoic acid; Sodium oxybate; Sodium oxybutyrate), including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
See also CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 12 Aug 1999, 64 FR 37673 added:
On 9 Apr 1999, 64 FR 17299 proposed to add:
Ketamine ((±)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone), its salts, isomers, and salts of isomers
CA: CDSA Schedule I Section 14 Subsection 1 Ketamine
UK: MDA Part II Class B Section 1(a) Ketamine and Part III Class C Section 1(a) Ketamine
PubChem: 3821; ChemSpider: 3689; Bluelight: Ketamine; Bluelight: Ketamine; Drugs Forum: Ketamine; Erowid: Ketamine; Wikipedia: Ketamine
CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
UN: Precursors Table I Lysergic acid
PubChem: 6717; ChemSpider: 6461; Wikipedia: Lysergic acid
UK: MDA Part I Class A Section 1(a) Lysergamide
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
CA: CDSA Schedule IV Section 17 Methyprylon
UK: MDA Part III Class C Section 1(a) Methyprylone
UN: Psychotropics Schedule IV Methyprylon
PubChem: 4162; ChemSpider: 4018; Wikipedia: Methyprylon
Effective 14 Mar 1977, 42 FR 8636 revoked (and renumbered subsequent entries):
US: Currently at CSA Schedule II Section e Subsection 4 Phencyclidine
Effective 2 Dec 2013, 78 FR 72013 added (and renumbered subsequent entries):
On 22 Oct 2013, 78 FR 62500 proposed to add (and to renumber subsequent entries):
Perampanel, and its salts, isomers, and salts of isomers
PubChem: 9924495; ChemSpider: 8100130; Wikipedia: Perampanel
PubChem: 75197; ChemSpider: 67743; Wikipedia: Tetronal
PubChem: 6433; ChemSpider: 6193; Wikipedia: Trional
PubChem: 8262; ChemSpider: 7964; Wikipedia: Sulfonmethane
Effective 20 Feb 1987, 52 FR 2221 added:
Tiletamine (2-(Ethylamino)-2-(2-thienyl)cyclohexanone) and Zolazepam (4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one; Flupyrazapon) or any salt thereof
PubChem: 26533; ChemSpider: 24714; Bluelight: Tiletamine; Drugs Forum: Tiletamine; Erowid: Tiletamine; Wikipedia: Tiletamine
PubChem: 35775; ChemSpider: 32907; Bluelight: Zolazepam; Drugs Forum: Zolazepam; Erowid: Zolazepam; Wikipedia: Zolazepam
CA: CDSA Schedule I Section 1 Subsection 23 Nalorphine
PubChem: 5284595; ChemSpider: 4447643; Wikipedia: Nalorphine
Narcotic Drugs. Unless specifically excepted or unless listed in another schedule:
Effective 7 Oct 2002, 67 FR 62354 replacement for:
On 21 Mar 2002, 67 FR 13114 proposed replacement for:
Narcotic Drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
Effective 7 Oct 2002, 67 FR 62354 added (and renumbered subsequent entries):
On 21 Mar 2002, 67 FR 13114 proposed to add (and to renumber subsequent entries):
Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
Not more than 1.8 grams of Codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of Opium
CA: CDSA Schedule I Section 1 Subsection 2 Codeine
UK: MDA Part II Class B Section 1(a) Codeine
UN: Narcotics Part 1 Section 2 Codeine and Part 2 Section 1 Codeine
See also CSA Schedule II Section b Subsection 1 Item i Codeine, Schedule III Section e Subsection 1 Item ii Codeine and Schedule V Section c Subsection 1 Codeine
PubChem: 5284371; ChemSpider: 4447447; Drugs Forum: Codeine; Erowid: Codeine; Wikipedia: Codeine
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UK: MDA Part I Class A Section 1(a) Opium
UN: Narcotics Part 1 Section 1 Opium, Part 2 Section 4 Opium and Section 7 Opium
See also CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item v Opium and Schedule V Section c Subsection 5 Opium
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: Opium
Not more than 1.8 grams of Codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
See also CSA Schedule II Section b Subsection 1 Item i Codeine, Schedule III Section e Subsection 1 Item i Codeine and Schedule V Section c Subsection 1 Codeine
Effective 6 Oct 2014, 79 FR 49661 revoked (and renumbered subsequent entries):
On 27 Feb 2014, 79 FR 11037 proposed to revoke (and to renumber subsequent entries:)
Not more than 300 milligrams of Dihydrocodeinone (Hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of Opium
CA: CDSA Schedule I Section 1 Subsection 15 Hydrocodone
UK: MDA Part I Class A Section 1(a) Hydrocodone
UN: Narcotics Part 1 Section 1 Hydrocodone
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
Not more than 300 milligrams of Dihydrocodeinone (Hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
Not more than 1.8 grams of Dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
CA: CDSA Schedule I Section 1 Subsection 11 Dihydrocodeine
UK: MDA Part II Class B Section 1(a) Dihydrocodeine
UN: Narcotics Part 1 Section 2 Dihydrocodeine and Part 2 Section 1 Dihydrocodeine
See also CSA Schedule II Section c Subsection 7 Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
PubChem: 5284543; ChemSpider: 4447600; Erowid: Dihydrocodeine; Wikipedia: Dihydrocodeine
Not more than 300 milligrams of Ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UK: MDA Part II Class B Section 1(a) Ethylmorphine
UN: Narcotics Part 1 Section 2 Ethylmorphine and Part 2 Section 1 Ethylmorphine
See also CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
PubChem: 5359271; ChemSpider: 4514250; Wikipedia: Ethylmorphine
Not more than 500 milligrams of Opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
See also CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium and Schedule V Section c Subsection 5 Opium
Not more than 50 milligrams of Morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
CA: CDSA Schedule I Section 1 Subsection 3 Morphine
UK: MDA Part I Class A Section 1(a) Morphine
UN: Narcotics Part 1 Section 1 Morphine and Part 2 Section 4 Morphine
See also CSA Schedule II Section b Subsection 1 Item ix Morphine
PubChem: 5288826; ChemSpider: 4450907; Bluelight: Morphine; Drugs Forum: Morphine; Erowid: Morphine; Wikipedia: Morphine
Effective 7 Oct 2002, 67 FR 62354 added:
On 21 Mar 2002, 67 FR 13114 proposed to add:
Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts as set forth below:
CA: CDSA Schedule I Section 10 Subsection 1 Buprenorphine
UK: MDA Part III Class C Section 1(a) Buprenorphine
UN: Psychotropics Schedule III Buprenorphine
US: Previously at CSA Schedule V Section b Subsection 1
PubChem: 40400 644073; ChemSpider: 559124; Bluelight: Buprenorphine; Drugs Forum: Buprenorphine; Erowid: Buprenorphine; Wikipedia: Buprenorphine
Effective 17 Jan 2006, 70 FR 74653 replacement for:
Effective 27 Feb 1991, 56 FR 5753 added:
Readers wanting to explore the intricacies of steroid nomenclature may find this steroid crib sheet useful.
Anabolic steroids (see §1300.01 of this chapter)
From 21 CFR 1300.01 Definitions relating to controlled substances
Effective 27 Jan 2012, 77 FR 4228 replacement for:
[From 21 CFR 1300.01 Definitions relating to controlled substances]
…(4) The term anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone), and includes:
[From 21 CFR 1308.02 Definitions]
…(b) The term anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins and corticosteroids) that promotes muscle growth, and includes:
Effective 27 Jan 2012, 77 FR 4228 renumbered:
Effective 17 Jan 2006, 70 FR 74653 added (and renumbered subsequent entries):
3β,17β-Dihydroxy-5α-androstane
PubChem: 242332; ChemSpider: 211834; Erowid: Steroids
3α,17β-Dihydroxy-5α-androstane
UK: MDA Part III Class C Section 1(b) 5α-Androstane-3,17-diol
PubChem: 15818; ChemSpider: 15039; Erowid: Steroids
5α-Androstan-3,17-dione
PubChem: 222865; ChemSpider: 193520; Erowid: Steroids
1-Androstenediol (3β,17β-Dihydroxy-5α-androst-1-ene)
ChemSpider: 9475742; Erowid: Steroids; Wikipedia: Prohormone
UK: MDA Part III Class C Section 1(b) 1-Androstenediol
PubChem: 11300765; ChemSpider: 9635329; Erowid: Steroids
4-Androstenediol (3β,17β-Dihydroxyandrost-4-ene)
UK: MDA Part III Class C Section 1(b) Androst-4-ene-3,17-diol
PubChem: 136297; ChemSpider: 120071; Erowid: Steroids; Wikipedia: 4-Androstenediol
5-Androstenediol (3β,17β-Dihydroxyandrost-5-ene)
CA: CDSA Schedule IV Section 23 Subsection 3 Androstenediol
UK: MDA Part III Class C Section 1(b) 5-Androstene-3,17-diol
PubChem: 10634; ChemSpider: 10188; Erowid: Steroids; Wikipedia: 5-Androstenediol
1-Androstenedione ([5α]-Androst-1-en-3,17-dione)
UK: MDA Part III Class C Section 1(b) 1-Androstenedione
PubChem: 11196935; ChemSpider: 9372004; Erowid: Steroids; Wikipedia: 1-Androstenedione
UK: MDA Part III Class C Section 1(b) 4-Androstene-3,17-dione
PubChem: 6128; ChemSpider: 5898; Erowid: Steroids; Wikipedia: Androstenedione
UK: MDA Part III Class C Section 1(b) 5-Androstenedione
PubChem: 160531; ChemSpider: 141063; Erowid: Steroids; Wikipedia: 5-Androstenedione
Bolasterone (7α,17α-Dimethyl-17β-hydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 5 Bolasterone
UK: MDA Part III Class C Section 1(b) Bolasterone
PubChem: 102146; ChemSpider: 92280; Erowid: Steroids; Wikipedia: Bolasterone
Boldenone (17β-Hydroxyandrost-1,4-diene-3-one)
Boldenone (17β-Hydroxyandrost-1,4,-diene-3-one)
CA: CDSA Schedule IV Section 23 Subsection 7 Boldenone
UK: MDA Part III Class C Section 1(b) Boldenone
PubChem: 13308; ChemSpider: 12744; Erowid: Steroids; Wikipedia: Boldenone
Effective 4 Jan 2010, 74 FR 63603 added (and renumbered subsequent entries):
On 25 Apr 2008, 73 FR 22294 proposed to add (and to renumber subsequent entries):
UK: MDA Part III Class C Section 1(b) Boldione
PubChem: 13472; ChemSpider: 12893; Erowid: Steroids; Wikipedia: Boldione
Calusterone (7β,17α-Dimethyl-17β-hydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 9 Calusterone
UK: MDA Part III Class C Section 1(b) Calusterone
PubChem: 28204; ChemSpider: 26239; Erowid: Steroids; Wikipedia: Calusterone
Effective 17 Jan 2006, 70 FR 74653 revoked:
Chlorotestosterone is a synonym for Clostebol
Clostebol (4-Chloro-17β-hydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 10 Clostebol
UK: MDA Part III Class C Section 1(b) Clostebol
PubChem: 68947; ChemSpider: 62171; Erowid: Steroids; Wikipedia: Clostebol
Dehydrochloromethyltestosterone (4-Chloro-17β-hydroxy-17α-methylandrost-1,4-dien-3-one)
UK: MDA Part III Class C Section 1(b) 4-Chloromethandienone
PubChem: 16395944; ChemSpider: 88972; Erowid: Steroids; Wikipedia: 4-Chlorodehydromethyltestosterone
Desoxymethyltestosterone (17α-Methyl-5α-androst-2-en-17β-ol; Madol)
UK: MDA Part III Class C Section 1(b) Desoxymethyltestosterone
PubChem: 18651; ChemSpider: 17611; Erowid: Steroids; Wikipedia: Desoxymethyltestosterone
Δ1-Dihydrotestosterone (1-Testosterone; 17β-Hydroxy-5α-androst-1-en-3-one)
PubChem: 236666; ChemSpider: 206590; Erowid: Steroids; Wikipedia: 1-Testosterone
4-Dihydrotestosterone (17β-Hydroxyandrostan-3-one)
CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
UK: MDA Part III Class C Section 1(b) Stanolone
PubChem: 10635; ChemSpider: 10189; Erowid: Steroids; Wikipedia: Dihydrotestosterone
Drostanolone (17β-Hydroxy-2α-methyl-5α-androstan-3-one)
CA: CDSA Schedule IV Section 23 Subsection 11 Drostanolone
UK: MDA Part III Class C Section 1(b) Drostanolone
PubChem: 6011; ChemSpider: 5789; Erowid: Steroids; Wikipedia: Drostanolone
Ethylestrenol (17α-Ethyl-17β-hydroxyestr-4-ene)
CA: CDSA Schedule IV Section 23 Subsection 14 Ethylestrenol
UK: MDA Part III Class C Section 1(b) Ethyloestrenol
PubChem: 13765; ChemSpider: 13168; Erowid: Steroids; Wikipedia: Ethylestrenol
Fluoxymesterone (9-Fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 16 Fluoxymesterone
UK: MDA Part III Class C Section 1(b) Fluoxymesterone
PubChem: 6446; ChemSpider: 6205; Erowid: Steroids; Wikipedia: Fluoxymesterone
Formebolone (2-Formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)
CA: CDSA Schedule IV Section 23 Subsection 17 Formebolone
UK: MDA Part III Class C Section 1(b) Formebolone
PubChem: 17150; ChemSpider: 16234; Erowid: Steroids; Wikipedia: Formebolone
Furazabol (17α-Methyl-17β-hydroxyandrostano[2,3-c]furazan)
CA: CDSA Schedule IV Section 23 Subsection 18 Furazabol
UK: MDA Part III Class C Section 1(b) Furazabol
PubChem: 14708; ChemSpider: 14032; Erowid: Steroids; Wikipedia: Furazabol
13β-Ethyl-17β-hydroxygon-4-en-3-one
Effective 13 Oct 2006, 71 FR 60426 replacement for:
13β-Ethyl-17α-hydroxygon-4-en-3-one
PubChem: 150854; ChemSpider: 8215338; Erowid: Steroids
[With thanks to Jan of Palo Alto for reporting an error in the structural diagram shown previously for this substance.]
PubChem: 160615; ChemSpider: 141138; Erowid: Steroids; Wikipedia: 4-Hydroxytestosterone
4-Hydroxy-19-nortestosterone (4,17β-Dihydroxy-estr-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 15 4-Hydroxy-19-nortestosterone
PubChem: 107580; ChemSpider: 16736429; Erowid: Steroids; Wikipedia: Oxabolone
Mestanolone (17α-Methyl-17β-hydroxy-5α-androstan-3-one)
UK: MDA Part III Class C Section 1(b) Mestanolone
PubChem: 10633; ChemSpider: 10187; Erowid: Steroids; Wikipedia: Mestanolone
Mesterolone (1α-Methyl-17β-hydroxy-[5α]-androstan-3-one)
Mesterolone (1αMethyl-17β-hydroxy-[5α]-androstan-3-one)
CA: CDSA Schedule IV Section 23 Subsection 21 Mesterolone
UK: MDA Part III Class C Section 1(b) Mesterolone
PubChem: 15020; ChemSpider: 14296; Erowid: Steroids; Wikipedia: Mesterolone
Methandienone (17α-Methyl-17β-hydroxyandrost-1,4-dien-3-one)
CA: CDSA Schedule IV Section 23 Subsection 22 Metandienone
UK: MDA Part III Class C Section 1(b) Methandienone
PubChem: 6300; ChemSpider: 6061; Erowid: Steroids; Wikipedia: Methandrostenolone
Methandriol (17α-Methyl-3β,17β-dihydroxyandrost-5-ene)
CA: CDSA Schedule IV Section 23 Subsection 24 Methandriol
UK: MDA Part III Class C Section 1(b) Methandriol
PubChem: 10632; ChemSpider: 199375; Erowid: Steroids; Wikipedia: Methandriol
Methandrostenolone is a synonym for Methandienone
Effective 29 Aug 2012, 77 FR 44456 added (and renumbered subsequent entries):
On 23 Nov 2011, 76 FR 72355 proposed to add (and to renumber subsequent entries):
Methasterone (2α,17α-Dimethyl-5α-androstan-17β-ol-3-one)
See also CSA Schedule III Section f Subsection 1 Item 73 2α,17α-Dimethyl-17β-hydroxy-5α-androstan-3-one
PubChem: 237186; ChemSpider: 207079; Bluelight: Superdrol; Erowid: Steroids; Wikipedia: Methasterone
Methenolone (1-Methyl-17β-hydroxy-5α-androst-1-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 23 Metenolone
UK: MDA Part III Class C Section 1(b) Methenolone
PubChem: 9054; ChemSpider: 2301378; Erowid: Steroids; Wikipedia: Metenolone
17α-Methyl-3β,17β-dihydroxy-5α-androstane
PubChem: 101819; ChemSpider: 91994; Erowid: Steroids
17α-Methyl-3α,17β-dihydroxy-5α-androstane
PubChem: 242493; ChemSpider: 211980; Erowid: Steroids
17α-Methyl-3β,17β-dihydroxyandrost-4-ene
Erowid: Steroids
17α-Methyl-4-hydroxynandrolone (17α-Methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one)
Methyldienolone (17α-Methyl-17β-hydroxyestra-4,9(10)-dien-3-one)
Erowid: Steroids; Wikipedia: Methyldienolone
Methyltrienolone (17α-Methyl-17β-hydroxyestra-4,9,11-trien-3-one)
Methyltrienolone (17α-Methyl-17β-hydroxyestra-4,9-11-trien-3-one)
CA: CDSA Schedule IV Section 23 Subsection 26 Metribolone
UK: MDA Part III Class C Section 1(b) Metribolone
PubChem: 261000; ChemSpider: 229099; Erowid: Steroids; Wikipedia: Metribolone
Methyltestosterone (17α-Methyl-17β-hydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 25 Methyltestosterone
UK: MDA Part III Class C Section 1(b) Methyltestosterone
PubChem: 6010; ChemSpider: 5788; Erowid: Steroids; Wikipedia: Methyltestosterone
Mibolerone (7α,17α-Dimethyl-17β-hydroxyestr-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 27 Mibolerone
UK: MDA Part III Class C Section 1(b) Mibolerone
PubChem: 19454; ChemSpider: 220460; Erowid: Steroids; Wikipedia: Mibolerone
17α-Methyl-Δ1-dihydrotestosterone (17β-Hydroxy-17α-methyl-5α-androst-1-en-3-one; 17α-Methyl-1-testosterone)
17α-Methyl-Δ1-dihydrotestosterone (17bβ-Hydroxy-17α-methyl-5α-androst-1-en-3-one; 17α-Methyl-1-testosterone)
PubChem: 7092657; ChemSpider: 5442174; Bluelight: Methyl-1-Testosterone; Drugs Forum: M-1-T; Erowid: Steroids; Wikipedia: Methyl-1-testosterone
Nandrolone (17β-Hydroxyestr-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 28 Nandrolone
UK: MDA Part III Class C Section 1(b) Nandrolone
PubChem: 9904; ChemSpider: 9520; Erowid: Steroids; Wikipedia: Nandrolone
19-Nor-4-androstenediol (3β,17β-Dihydroxyestr-4-ene)
CA: CDSA Schedule IV Section 23 Subsection 4 Bolandiol
UK: MDA Part III Class C Section 1(b) Bolandiol
PubChem: 9835303; ChemSpider: 8011024; Erowid: Steroids; Wikipedia: Bolandiol
PubChem: 16760418; ChemSpider: 8097336; Erowid: Steroids; Wikipedia: Bolandiol
19-Nor-5-androstenediol (3β,17β-Dihydroxyestr-5-ene)
UK: MDA Part III Class C Section 1(b) 19-Nor-5-androstene-3,17-diol
PubChem: 23623203; ChemSpider: 19967184; Erowid: Steroids; Wikipedia: Bolandiol
19-Nor-5-androstenediol (3α,17β-Dihydroxyestr-5-ene)
PubChem: 9856842; ChemSpider: 8032542; Erowid: Steroids; Wikipedia: Bolandiol
19-Nor-4,9(10)-androstadienedione (Estra-4,9(10)-diene-3,17-dione)
PubChem: 9835169; ChemSpider: 8010890; Erowid: Steroids; Wikipedia: Dienedione
19-Nor-4-androstenedione (Estr-4-en-3,17-dione)
UK: MDA Part III Class C Section 1(b) 19-Nor-4-androstene-3,17-dione
PubChem: 10221133; ChemSpider: 83803; Erowid: Steroids; Wikipedia: 19-Norandrostenedione
UK: MDA Part III Class C Section 1(b) 19-Norandrostenedione
PubChem: 18633059; ChemSpider: 18612511; Erowid: Steroids; Wikipedia: 19-Norandrostenedione
Norbolethone (13β,17α-Diethyl-17β-hydroxygon-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 29 Norboletone
UK: MDA Part III Class C Section 1(b) Norboletone
PubChem: 66255; ChemSpider: 59638; Erowid: Steroids; Wikipedia: Norbolethone
Norclostebol (4-Chloro-17β-hydroxyestr-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 30 Norclostebol
UK: MDA Part III Class C Section 1(b) Norclostebol
PubChem: 166576; ChemSpider: 145769; Erowid: Steroids; Wikipedia: Norclostebol
Norethandrolone (17α-Ethyl-17β-hydroxyestr-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 31 Norethandrolone
UK: MDA Part III Class C Section 1(b) Norethandrolone
PubChem: 5858; ChemSpider: 5649; Erowid: Steroids; Wikipedia: Norethandrolone
Normethandrolone (17α-Methyl-17β-hydroxyestr-4-en-3-one)
PubChem: 5284597; ChemSpider: 4447645; Erowid: Steroids; Wikipedia: Methylestrenolone
Oxandrolone (17α-Methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one)
CA: CDSA Schedule IV Section 23 Subsection 33 Oxandrolone
UK: MDA Part III Class C Section 1(b) Oxandrolone
PubChem: 5878; ChemSpider: 5667; Bluelight: Oxandrolone; Drugs Forum: Oxandrolone; Erowid: Steroids; Wikipedia: Oxandrolone
Oxymesterone (17α-Methyl-4,17β-dihydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 34 Oxymesterone
UK: MDA Part III Class C Section 1(b) Oxymesterone
PubChem: 72061; ChemSpider: 65047; Erowid: Steroids; Wikipedia: Oxymesterone
Oxymetholone (17α-Methyl-2-hydroxymethylene-17β-hydroxy-[5α]-androstan-3-one)
CA: CDSA Schedule IV Section 23 Subsection 35 Oxymetholone
UK: MDA Part III Class C Section 1(b) Oxymetholone
PubChem: 3032303; ChemSpider: 4444502; Bluelight: Oxymetholone; Erowid: Steroids; Wikipedia: Oxymetholone
Prostanozol, O-tetrahydropyran-2-yl
[There is much confusion surrounding the name Prostanozol. The culprit seems to be the World Anti-Doping Agency (WADA), which every year updates their list of Prohibited Substances.
For 2009 (and later) it reads:
Prostanozol (17β-Hydroxy-5α-androstano[3,2-c]pyrazole), depicted at left, above.
For 2008 (and earlier) it reads:
Prostanozol ([3,2-c]pyrazole-5α-etioallocholane-17β-tetrahydropyranol), depicted at left, below.
Given these names describe distinctly different substances WADA’s explanation—“The nomenclature of Prostanozol has been changed to better follow the International Union of Pure and Applied Chemistry (IUPAC) rules”—has a certain… CYA quality. Not very helpful WADA. Definitely not very sporting.]
UK: MDA Part III Class C Section 1(b) Prostanozol
See also CSA Schedule III Section f Subsection 1 Item 89 [3,2-c]Pyrazole-5α-androstan-17β-ol
ChemSpider: 10071620; Erowid: Steroids; Wikipedia: Prostanozol
UK: MDA Part III Class C Section 1(b) Prostanozol, O-tetrahydropyran-2-yl
PubChem: 56842253; Erowid: Steroids; Wikipedia: Prostanozol
Stanolone is a synonym for 4-Dihydrotestosterone
Stanozolol (17α-Methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]pyrazole)
Stanozolol (17α-Methyl-17α-hydroxy-[5α]-androst-2-eno[3,2-c]pyrazole)
CA: CDSA Schedule IV Section 23 Subsection 38 Stanozolol
UK: MDA Part III Class C Section 1(b) Stanozolol
PubChem: 25249; ChemSpider: 23582; Bluelight: Stanozolol; Erowid: Steroids; Wikipedia: Stanozolol
Stenbolone (17β-Hydroxy-2-methyl-[5α]-androst-1-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 39 Stenbolone
UK: MDA Part III Class C Section 1(b) Stenbolone
PubChem: 234454; ChemSpider: 204491; Erowid: Steroids; Wikipedia: Stenbolone
Testolactone (13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)
PubChem: 13769; ChemSpider: 13172; Erowid: Steroids; Wikipedia: Testolactone
Testosterone (17β-Hydroxyandrost-4-en-3-one)
CA: CDSA Schedule IV Section 23 Subsection 40 Testosterone
UK: MDA Part III Class C Section 1(b) Testosterone
PubChem: 6013; ChemSpider: 5791; Erowid: Steroids; Wikipedia: Testosterone
Tetrahydrogestrinone (13β,17α-Diethyl-17β-hydroxygon-4,9,11-trien-3-one)
UK: MDA Part III Class C Section 1(b) Tetrahydrogestrinone
PubChem: 25320811 6857686; ChemSpider: 5257020; Bluelight: Tetrahydrogestrinone; Erowid: Steroids; Wikipedia: Tetrahydrogestrinone
CA: CDSA Schedule IV Section 23 Subsection 43 Trenbolone
UK: MDA Part III Class C Section 1(b) Trenbolone
PubChem: 25015; ChemSpider: 23383; Erowid: Steroids; Wikipedia: Trenbolone
Effective 18 Dec 2014, H.R. 4771, 113 Cong., 2nd Sess. added:
PubChem: 11522319; ChemSpider: 9697106
PubChem: 25170577
See also CSA Schedule III Section f Subsection 1 Item 72 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol
PubChem: 71314774; ChemSpider: 31046818
Bluelight: Promag
PubChem: 67874349; ChemSpider: 197559
See also CSA Schedule III Section f Subsection 1 Item 68 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol
See also CSA Schedule III Section f Subsection 1 Item 32 Methasterone
PubChem: 237186; ChemSpider: 207079; Wikipedia: Methasterone
PubChem: 71752521; ChemSpider: 24749347
PubChem: 54252444
PubChem: 160762; ChemSpider: 141254
PubChem: 11722357; ChemSpider: 9897073
PubChem: 54523413
4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol [sic]
PubChem: 11273; ChemSpider: 10799; Wikipedia: Formestane
See also CSA Schedule III Section f Subsection 1 Item 58 Prostanozol
Effective 18 Dec 2014, H.R. 4771, 113 Cong., 2nd Sess. renumbered:
Effective 17 Jan 2006, 70 FR 74653 added:
Effective 2 Jul 1999, 64 FR 35928 added:
On 5 Nov 1998, 63 FR 59751 proposed to add:
Dronabinol ((6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; (–)-Delta-9-(trans)-tetrahydrocannabinol) (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product
UN: Psychotropics Schedule II Dronabinol (delta-9-Tetrahydrocannabinol)
PubChem: 16078 2978; ChemSpider: 4479482; Erowid: Dronabinol; Wikipedia: Dronabinol
11 March 2016 · · Isomer Design